AN2 Therapeutics, Inc.

ANTX·NASDAQ·$3.34Share Price as of 11/2·$110MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/11/26 10-KFY 202503/17/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report08/11/26 8-KCurrent report06/09/26 8-KCurrent report06/04/26 8-KCurrent report05/11/26 8-KCurrent report04/09/26

Prospectuses and Registrations

S-8Registration of securities for employees09/14/26 424B3Prospectus04/20/26 424B5Prospectus supplement04/20/26 S-3Shelf registration04/09/26 S-8Registration of securities for employees03/17/26

Proxies

DEF 14ADefinitive proxy04/22/26 DEFA14AAdditional proxy materials04/22/26 DEF 14ADefinitive proxy04/10/25 DEFA14AAdditional proxy materials04/10/25 DEF 14ADefinitive proxy04/26/24

Ownership

Form 4Insider transaction10/13/26 Form 4Insider transaction10/13/26 Form 4Insider transaction10/13/26 Form 4Insider transaction09/16/26 Form 4Insider transaction09/11/26

Other

ARSAnnual report to shareholders04/22/26 EFFECTRequest for effectiveness04/20/26 CORRESPCorrespondence with the SEC04/16/26 UPLOADLetter from the SEC04/15/26 DD03/25/26